Risa Tamagawa-Mineoka
Overview
Explore the profile of Risa Tamagawa-Mineoka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
423
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arakawa Y, Tamagawa-Mineoka R, Ueta M, Nakanishi M, Nishigaki H, Katoh N
Exp Dermatol
. 2025 Mar;
34(3):e70074.
PMID: 40066904
Ikaros, which is encoded by the Ikaros family zinc finger 1 (IKZF1) gene, is a zinc finger transcription factor. We have previously generated K5-Ikzf1-EGFP transgenic mice (Ikzf1 Tg) by introducing...
2.
Nakanishi M, Tamagawa-Mineoka R, Nishigaki H, Arakawa Y, Ohtsuka S, Katoh N
Exp Dermatol
. 2025 Feb;
34(2):e70064.
PMID: 39967561
Atopic dermatitis (AD) is a common skin disease. Although AD pathogenesis has been widely researched, inhibitory mechanisms in AD are still unclear. Sialic acid-binding immunoglobulin-like lectins (Siglecs) are a family...
3.
Kawasaki-Nagano M, Tamagawa-Mineoka R, Kurioka T, Arakawa Y, Nakanishi M, Kishida M, et al.
Exp Dermatol
. 2024 Nov;
33(11):e70015.
PMID: 39513758
Platelet-activating factor (PAF) is an important chemical mediator in the field of inflammation, but its function in the skin is unclear. To unravel the role of PAF, we focused on...
4.
Kido-Nakahara M, Onozuka D, Izuhara K, Saeki H, Nunomura S, Takenaka M, et al.
J Allergy Clin Immunol Glob
. 2024 Sep;
3(4):100317.
PMID: 39253106
Background: Atopic dermatitis (AD) is a common chronic eczematous skin disease with severe pruritus. Several new therapeutic agents for AD such as dupilumab, an anti-IL-4Rα antibody, have been developed in...
5.
Tamagawa-Mineoka R, Taniguchi M, Ioka N, Hattori J, Mizutani H, Masuda K, et al.
Contact Dermatitis
. 2024 May;
91(3):259-260.
PMID: 38757244
No abstract available.
6.
Kido-Nakahara M, Onozuka D, Izuhara K, Saeki H, Nunomura S, Takenaka M, et al.
Allergol Int
. 2023 Dec;
73(2):332-334.
PMID: 38151410
No abstract available.
7.
Nakahara T, Onozuka D, Nunomura S, Saeki H, Takenaka M, Matsumoto M, et al.
J Allergy Clin Immunol Glob
. 2023 Nov;
3(1):100175.
PMID: 37915726
Background: To develop precision medicine for atopic dermatitis (AD), it is critical to establish relevant biomarkers. However, the characteristics of various biomarkers have not been fully understood. We previously carried...
8.
Tamagawa-Mineoka R
Front Immunol
. 2023 Sep;
14:1239244.
PMID: 37731494
The skin functions as a physical barrier and represents the first line of the innate immune system. There is increasing evidence that toll-like receptors (TLRs) are involved in the pathomechanisms...
9.
Matsumoto K, Ueta M, Inatomi T, Fukuoka H, Mieno H, Tamagawa-Mineoka R, et al.
Am J Ophthalmol
. 2023 May;
253:142-151.
PMID: 37182731
Purpose: To clarify the importance of administering topical steroids for the treatment of Stevens-Johnson syndrome (SJS) / toxic epidermal necrolysis (TEN) with ocular involvement in the acute phase. Design: Retrospective...
10.
Kishimoto S, Watanabe N, Yamamoto Y, Imai T, Aida R, Germer C, et al.
JAMA Dermatol
. 2023 May;
159(6):628-636.
PMID: 37163257
Importance: Quality of life (QOL) of patients with atopic dermatitis (AD) is reported to be the lowest among skin diseases. To our knowledge, mindfulness and self-compassion training has not been...